IVERMECTIN & FENBENDAZOLE: HOW THEY WORK TOGETHER
Ivermectin and Fenbendazole are both anti-parasitic drugs (anthelmintics), but they act through different mechanisms and target different areas of the body. When used strategically—whether in rotation or combination—they may offer broad-spectrum support against parasites and other chronic conditions.
Ivermectin
Mechanism: Binds to glutamate-gated chloride channels in parasite nerve and muscle cells, causing paralysis and death.
Targets: Blood parasites, filarial worms, lice, mites, and some gastrointestinal worms.
Strengths: Deep tissue penetration—including the brain, lungs, and skin.
Best for: Systemic infections affecting the nervous system, lungs, blood, and skin.
Fenbendazole
Mechanism: Disrupts microtubule formation by binding to beta-tubulin, preventing parasite cells from absorbing nutrients and reproducing.
Targets: Primarily gastrointestinal parasites (roundworms, hookworms, whipworms, some tapeworms).
Strengths: Works locally in the digestive tract and affects parasite metabolism.
Best for: Intestinal parasitic infections.
Why Use Them Together?
BenefitExplanationBroader coverageTargets more parasite types across more tissues.Reduced resistanceDifferent mechanisms lower the chance of parasites adapting.Tissue synergyIvermectin reaches deep tissues; Fenbendazole works in digestive and detox organs.Biofilm disruptionFenbendazole may weaken defenses, allowing Ivermectin to act more effectively.
Protocol Tips (Always Under Medical Guidance)
• Cycle: Often used in 3–5 day on/off cycles or rotated weekly.
• Binders: Some people use activated charcoal or bentonite clay to support detoxification.
• Detox support: Support liver and kidney function as advised by a healthcare professional.
• Hydration: Stay well hydrated and replenish electrolytes.
Comment "Protocol ” to my WhatsApp and get the complete parasite protocol Kit.
Email: [email protected]
I’ve personally decided there are three types of people, and only three. 👀
One sees what is in front of them, does the research, and knows the truth.
Two is basically ignorant and believes whatever they’re told by outside sources.
Three sees the truth but refuses to believe it - that’s cognitive dissonance.
So there’s that.
On August 11, vaccine pusher Michael, who runs Life by Michael and has 1.2 million followers on Facebook, shared a message as a 42-year-old single dad: “I’m not a doctor. I just choose facts for my kids.” He wrote about measles making a comeback, warning people not to become complacent or let politics and misinformation get in the way of evidence, and pointing out that vaccines had helped make these diseases rare.
Then, a month later, he was posting from his couch with a pill box.
At 42, Michael had suffered a heart attack. He initially thought the chest and arm pain was coming from his stomach. Doctors found that his right coronary artery was completely blocked.
He survived. He listened. And he later said that men need to stop pretending they’re fine when something feels wrong.
He had urged parents to trust the evidence. Then his own heart needed medication and a pill box just to keep track of what he needed to take each day.
That was the post he wrote.
And then came the post nobody expected.
In 2022, she was swabbing members of the public. Now she’s wearing a hospital bracelet, waiting for another blood draw while doctors monitor her rising heart enzyme levels.
On February 10, 2022, Lisette Rivera-Niroda from Pennsylvania was a certified CNA starting her first contract as an independent PCR COVID-19 testing technician. It was a side hustle: she swabbed both kids and adults and was excited, if nervous, about putting her number out there so laboratories could hire her.
Now she’s in the ER.
She initially thought the discomfort was indigestion. It turned out to be a mild heart attack. Her troponin was elevated and continued to rise, and cardiology was monitoring her. She described the chest pain as something she wouldn’t wish on anyone.
She wants the pain to stop. She wants everything to be okay. She’s asking for prayers.
Same woman. Same page.
She’s waiting to find out what comes next.
In December 2021, Gail Seiler was hospitalized in Texas after becoming seriously ill with COVID-19.
According to Seiler, once hospital staff knew she was unvaccinated, her experience took a turn she says she still struggles to understand.
She testified that she spent days isolated from her family, went 12 days without food and 7 days without water, and was listed as DNR despite her and her family’s objections.
She also described being pressured toward remdesivir and ventilation while requests for other treatments were refused.
Her husband, Brad, ultimately fought to get her out of the hospital.
Gail survived.
Years later, she sat before Sen. Ron Johnson’s September 2026 roundtable on COVID-19 hospital protocols and publicly recounted what she says happened to her.
Whatever conclusions people draw from her story, one thing is undeniable:
She lived through it - and she came forward to tell her story.
A food-system fellowship connected to the School for Moral Ambition has specifically focused on young American men aged 16–24, looking at how fitness influencers, podcasters and ideas about masculinity could be used to change attitudes toward meat.
The School for Moral Ambition received a $75,000 grant from the Bill & Melinda Gates Foundation in February 2025.
The strategy is remarkably explicit: use identity, culture and trusted “in-group” voices rather than simply lecturing people about nutrition.
The organisation involved, People for Better Food, says its work aims to “fundamentally reshape cultural beliefs about meat and plant-based eating.” Its Plants for the Win campaign uses gym culture, protein and performance messaging to make plant-based eating more appealing to young men.
The reported ambitions go beyond teenagers, too.
One fellow described the potential impact as reaching their diets, their future children’s diets, and generations to come.
So the interesting question isn’t simply:
“Should people eat less meat?”
People can make that choice for themselves.
The bigger question is:
Who gets to decide how the next generation is persuaded to change its behaviour — and how much influence should wealthy foundations and strategically funded organisations have over that process?
Because once food stops being just food and becomes a project involving identity, culture, influencers, schools, public procurement and future generations, it’s worth paying attention to exactly who’s funding it, who’s designing it and what the stated objectives actually are.
Read the documents. Follow the money. Then make up your own mind.
Read the grant trail here:
https://t.co/WXJ1lVv1jj…
DRINK THIS WHEN YOU’RE NOT FEELING WELL
• Ginger tea – for nausea and upset stomach
• Honey lemon tea – for sore throats
• Peppermint tea – for bloating and indigestion
• Coconut water – for dehydration
• Turmeric tea – for inflammation support
• Green tea – for antioxidants and immune support
• Chamomile tea – for stress and rest
• Warm water with cinnamon – for blood sugar support
• Fennel tea – for gas and bloating
• Elderberry tea – for seasonal immune support
• Thyme tea – for coughs and congestion
• Ginger lemon water – for sluggish digestion
• Hibiscus tea – for hydration and circulation
• Clove tea – for throat and mouth discomfort
• Marshmallow root tea – for a dry, irritated throat
• Rooibos tea – for gentle hydration and antioxidants
• Warm water with raw honey – for soothing the throat
• Chicken soup broth – for fluids, electrolytes, and comfort
🧬 A Virus That Fights Cancer? Japan Just Approved One.
What if a virus could be designed to attack cancer instead of healthy tissue?
Japan has approved **Telomelysin**, a genetically modified adenovirus designed to multiply inside cancer cells and destroy them. The treatment is injected directly into an esophageal tumor using an endoscope and is given alongside radiation therapy.
But there’s an important catch.
Telomelysin is **not for every esophageal cancer patient**. Its approved use is for patients who cannot undergo curative surgery or chemoradiotherapy.
The treatment was scheduled to go on sale in Japan on **August 21, 2026**. The listed price is about **¥3.1 million per vial**, with a typical three-dose course costing around **¥9.3 million** before insurance coverage.
It’s a fascinating new chapter in cancer treatment: **using a modified virus as a weapon against tumors.**
*Important: Telomelysin is an approved treatment in Japan for a specific patient group—not a universal cancer cure.*
**Source: Oncolys BioPharma Inc. (2026). *Telomelysin (OBP-301) / Telomelysin product information.*
🧬 A Virus That Fights Cancer? Japan Just Approved One.
What if a virus could be designed to attack cancer instead of healthy tissue?
Japan has approved **Telomelysin**, a genetically modified adenovirus designed to multiply inside cancer cells and destroy them. The treatment is injected directly into an esophageal tumor using an endoscope and is given alongside radiation therapy.
But there’s an important catch.
Telomelysin is **not for every esophageal cancer patient**. Its approved use is for patients who cannot undergo curative surgery or chemoradiotherapy.
The treatment was scheduled to go on sale in Japan on **August 21, 2026**. The listed price is about **¥3.1 million per vial**, with a typical three-dose course costing around **¥9.3 million** before insurance coverage.
It’s a fascinating new chapter in cancer treatment: **using a modified virus as a weapon against tumors.**
*Important: Telomelysin is an approved treatment in Japan for a specific patient group—not a universal cancer cure.*
**Source: Oncolys BioPharma Inc. (2026). *Telomelysin (OBP-301) / Telomelysin product information.*
🧬 A Virus That Fights Cancer? Japan Just Approved One.
What if a virus could be designed to attack cancer instead of healthy tissue?
Japan has approved **Telomelysin**, a genetically modified adenovirus designed to multiply inside cancer cells and destroy them. The treatment is injected directly into an esophageal tumor using an endoscope and is given alongside radiation therapy.
But there’s an important catch.
Telomelysin is **not for every esophageal cancer patient**. Its approved use is for patients who cannot undergo curative surgery or chemoradiotherapy.
The treatment was scheduled to go on sale in Japan on **August 21, 2026**. The listed price is about **¥3.1 million per vial**, with a typical three-dose course costing around **¥9.3 million** before insurance coverage.
It’s a fascinating new chapter in cancer treatment: **using a modified virus as a weapon against tumors.**
*Important: Telomelysin is an approved treatment in Japan for a specific patient group—not a universal cancer cure.*
**Source: Oncolys BioPharma Inc. (2026). *Telomelysin (OBP-301) / Telomelysin product information.*
COVID INJECTED AMERICANS CRIED OUT FOR HELP IN THEIR POST INJECTION CDC TEXT SURVEY...
The Covid injectables were developed at "warp speed", and when they were "authorised" by drug regulators there was a plethora of missing safety and efficacy data....and ZERO long term safety data.
This is why they were not fully approved, but instead given a Provisional Consent (in NZ) or an Emergency Use Authorisation (USA).
Both mRNA and the Lipid Nano Particles encasing it had never, ever, ever before been used in a population wide commercial product.
This was new and unchartered territory
Thus, POST MARKETING SURVEILLANCE was of utmost importance....both the manufacturers and the drug regulators KNEW that adverse events not seen in the clinical trials, would become evident when used population wide.
In America, as well as the voluntary passive reporting system (VAERS) for collecting adverse event reports....there was an active surveillance system too.
Millions of Americans were sent text messages after their injections, with invitations to complete a text survey about their post injection health.
A Freedom of Information request resulted in the eventual release of 7.5 million of these responses (from almost 3.5 million unique individuals)
These responses have now been analysed by American Covid injection injury group React19 @react19
Using search words indicating: cries for help; desire to die; suicidality....and death.
One in every 1,048 V Safe respondents registered a plea for help or a death.
3,329 people registered:
*serious harm
*suicidal thoughts
*near death events
*death of a loved one
You can now read these dire V Safe responses....many of them desperately and repeatedly asking the CDC for HELP
Link in comments
My mom, as a fair-skinned ginger who lived in perpetual fear of the sun her whole life, religiously wore sunscreen on her face and all exposed skin, including her ears, for 40+ years.
Her skin was NEVER exposed to bare sun since she was a child.
Our sun did not cause this.
It never does.
So in case you needed to see 100% proof of the cause of skin cancer, here is your sign.
STOP posioning the largest organ on your body with toxic chemicals and then literally BAKING it into your pores.
You have been warned.
Fauci told everyone that "HIV" could spread via Close Contact and on Household Surfaces.
If he was so confident in telling people something so wrong, is it not totally possible the entire thing was a lie?
🧬 A Cancer Vaccine That Could Wake Up the Immune System
Scientists at the University of Florida are testing an experimental mRNA approach that could change how some difficult cancers are treated.
The intriguing part? Instead of targeting one specific cancer protein, the vaccine appears to activate the immune system like an alarm, increasing type-I interferon signals and helping immune cells recognize tumors more effectively.
In mouse studies, this triggered epitope spreading—allowing the immune response to recognize multiple tumor targets. The treatment also helped make previously resistant tumors more vulnerable to immunotherapy.
The idea is still experimental, and it is not yet a universal cancer vaccine or a replacement for chemotherapy and radiation. But researchers are exploring whether this immune “wake-up call” could eventually work against many hard-to-treat cancers.
The mystery now is whether the remarkable results seen in animals can translate into lasting benefits for people.
Source: Qdaisat, S., et al. Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading. Nature Biomedical Engineering.
🚨New study of 197 cancer patients treated with Ivermectin (25 mg) + Mebendazole (250 mg):
After 6 months:
• 84.4% had clinical benefit
• 48.4% had tumor reduction or no detectable disease • 86.9% completed treatment with mild side effects Dr. Peter McCullough explains. Details ⬇️